Werfel, T.; Lynch, V; Asher, A. et al.
A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389), a potent, oral histamine H-4 receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adultsALLERGY. Bd. 71. 2016 S. 95-95
Voykov, Bogomil; Lorenz, Katrin; Schuart, Claudia et al.
A phase I First-In Human single ascending dose study of ISTH0036, a potent and selective antisense oligonucleotide targeting transforming growth factor beta 2 (TGF-beta 2) for the treatment of primary open-angle glaucomaINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. Bd. 57. H. 12. 2016
Van Damme, Pierre; Meijer, Chris J. L. M.; Kieninger, Dorothee et al.
A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in menVACCINE. Bd. 34. H. 35. 2016 S. 4205-4212
Barten, Markus J.; Schulz, Uwe; Beiras-Fernandez, Andres et al.
A Proposal for Early Dosing Regimens in Heart Transplant Patients Receiving Thymoglobulin and Calcineurin InhibitionTRANSPLANTATION DIRECT. Bd. 2. H. 6. 2016
Harris, Jeffrey M.; Cabanski, Christopher R.; Scheerens, Heleen et al.
A randomized trial of quilizumab in adults with refractory chronic spontaneous urticariaJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 138. H. 6. 2016 S. 1730-1732
Zhu, A. X.; Galle, P. R.; Kudo, M. et al.
A randomized, double-blind, placebo-controlled phase III study of ramucirumab versus placebo as second-line treatment in patients with hepatocellular carcinoma and elevated baseline alpha-fetoprotein following first-line sorafenib (REACH-2)ANNALS OF ONCOLOGY. Bd. 27. 2016
Zhu, Andrew X.; Galle, Peter R.; Kudo, Masatoshi et al.
A randomized, double-blind, placebo-controlled phase III study of ramucirumab versus placebo as second-line treatment in patients with hepatocellular carcinoma and elevated baseline alpha-fetoprotein following first-line sorafenib (REACH-2).JOURNAL OF CLINICAL ONCOLOGY. Bd. 34. H. 4. 2016
Schmitt, V.; Seidel, P.; Schnorbus, B. et al.
A rare Case of a Levetiracetam-induced RhabdomyolysisMEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN. Bd. 111. H. 4. 2016 S. 377-378
Brueggemann, Felix B.; Bartsch, Oliver
A recurrent TP63 mutation causing EEC3 and Rapp-Hodgkin syndromesCLINICAL DYSMORPHOLOGY. Bd. 25. H. 2. 2016 S. 50-53
Kalder, M.; Mueller, T.; Fischer, D. et al.
A Review of Integrative Medicine in Gynaecological OncologyGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 76. H. 2. 2016 S. 150-155